rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2006-7-17
|
pubmed:abstractText |
This study sought to analyze the cost of percutaneous coronary interventions with use of sirolimus-eluting stents (SES) or paclitaxel-eluting stents (PES) in patients at high risk of restenosis.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1558-3597
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
18
|
pubmed:volume |
48
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
262-7
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:16843172-Aged,
pubmed-meshheading:16843172-Angioplasty, Balloon, Coronary,
pubmed-meshheading:16843172-Cardiovascular Agents,
pubmed-meshheading:16843172-Coronary Disease,
pubmed-meshheading:16843172-Coronary Restenosis,
pubmed-meshheading:16843172-Cost Savings,
pubmed-meshheading:16843172-Costs and Cost Analysis,
pubmed-meshheading:16843172-Diabetic Angiopathies,
pubmed-meshheading:16843172-Female,
pubmed-meshheading:16843172-Germany,
pubmed-meshheading:16843172-Health Services,
pubmed-meshheading:16843172-Hospital Costs,
pubmed-meshheading:16843172-Hospitalization,
pubmed-meshheading:16843172-Humans,
pubmed-meshheading:16843172-Male,
pubmed-meshheading:16843172-Middle Aged,
pubmed-meshheading:16843172-Paclitaxel,
pubmed-meshheading:16843172-Randomized Controlled Trials as Topic,
pubmed-meshheading:16843172-Sirolimus
|
pubmed:year |
2006
|
pubmed:articleTitle |
Cost analysis from two randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in high-risk patients with coronary artery disease.
|
pubmed:affiliation |
Deutsches Herzzentrum, Technische Universität; Munich, Germany.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|